BioCentury | Jul 9, 2020
Product Development

CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials

...for Epidemic Preparedness Innovations (CEPI) GlaxoSmithKline plc Dynavax Technologies Corp. Medicago Inc. Emergent BioSolutions Inc. Mount Sinai Hospital U.S. Department of Defense Erasmus MC Biomedical Gilead...
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Premier League teams

...A) OrbiMed Advisors; Seventure Partners; Forbion Capital Partners; Credit Agricole; LSP-Life Sciences Partners; BioGeneration Ventures; Erasmus MC Biomedical...
BioCentury | Mar 10, 2014
Finance

Innovator capital rationing

...CD27L) now in Phase Ib for cancer $62 Series A, B BioGeneration Ventures, Credit Agricole, Erasmus MC Biomedical...
BioCentury | Sep 24, 2012
Emerging Company Profile

Arcarios: Protecting chondrocytes

...of employees: 20 Funds raised: €4.1 million ($5.4 million) Investors: Baekeland; BioGeneration Ventures; Omnes Capital; Erasmus MC Biomedical...
BioCentury | Dec 5, 2011
Financial News

arGEN-X completes venture financing

...Investors: OrbiMed Advisors; Seventure Partners; Forbion Capital Partners; Credit Agricole; LSP-Life Sciences Partners; BioGeneration Ventures; Erasmus MC Biomedical...
BioCentury | Sep 13, 2010
Financial News

Arcarios completes venture financing

...9/8/10 Type: Venture financing Raised: €4.1 million ($5.3 million) Investors: BioGeneration Ventures; TiGenix N.V. ; Erasmus MC Biomedical...
BioCentury | Sep 14, 2009
Financial News

arGEN-X completes venture financing

...million ($13.6 million) Investors: Forbion Capital Partners; Life Sciences Partners; KBC Private Equity; BioGeneration Ventures; Erasmus MC Biomedical...
BioCentury | Sep 11, 2009
Financial News

arGEN-X raises EUR 9.5 million

...Partners and Life Sciences Partners (LSP). KBC Private Equity and BioGeneration Ventures and existing investors Erasmus MC Biomedical...
BioCentury | Jul 6, 2009
Emerging Company Profile

Bactrian vs. dromedary: Sidebar: Corporate Profile

...Rotterdam Corporate partners: None Number of employees: 4 Funds raised: €1 million ($1.4 million) Investors: Erasmus MC Biomedical...
BioCentury | Jun 22, 2009
Finance

Ebb & Flow

...general counsel at LSP. Schwarz and de Vries are also managing the €20 million Rotterdam-focused Erasmus MC Biomedical...
Items per page:
1 - 10 of 10
BioCentury | Jul 9, 2020
Product Development

CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials

...for Epidemic Preparedness Innovations (CEPI) GlaxoSmithKline plc Dynavax Technologies Corp. Medicago Inc. Emergent BioSolutions Inc. Mount Sinai Hospital U.S. Department of Defense Erasmus MC Biomedical Gilead...
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Premier League teams

...A) OrbiMed Advisors; Seventure Partners; Forbion Capital Partners; Credit Agricole; LSP-Life Sciences Partners; BioGeneration Ventures; Erasmus MC Biomedical...
BioCentury | Mar 10, 2014
Finance

Innovator capital rationing

...CD27L) now in Phase Ib for cancer $62 Series A, B BioGeneration Ventures, Credit Agricole, Erasmus MC Biomedical...
BioCentury | Sep 24, 2012
Emerging Company Profile

Arcarios: Protecting chondrocytes

...of employees: 20 Funds raised: €4.1 million ($5.4 million) Investors: Baekeland; BioGeneration Ventures; Omnes Capital; Erasmus MC Biomedical...
BioCentury | Dec 5, 2011
Financial News

arGEN-X completes venture financing

...Investors: OrbiMed Advisors; Seventure Partners; Forbion Capital Partners; Credit Agricole; LSP-Life Sciences Partners; BioGeneration Ventures; Erasmus MC Biomedical...
BioCentury | Sep 13, 2010
Financial News

Arcarios completes venture financing

...9/8/10 Type: Venture financing Raised: €4.1 million ($5.3 million) Investors: BioGeneration Ventures; TiGenix N.V. ; Erasmus MC Biomedical...
BioCentury | Sep 14, 2009
Financial News

arGEN-X completes venture financing

...million ($13.6 million) Investors: Forbion Capital Partners; Life Sciences Partners; KBC Private Equity; BioGeneration Ventures; Erasmus MC Biomedical...
BioCentury | Sep 11, 2009
Financial News

arGEN-X raises EUR 9.5 million

...Partners and Life Sciences Partners (LSP). KBC Private Equity and BioGeneration Ventures and existing investors Erasmus MC Biomedical...
BioCentury | Jul 6, 2009
Emerging Company Profile

Bactrian vs. dromedary: Sidebar: Corporate Profile

...Rotterdam Corporate partners: None Number of employees: 4 Funds raised: €1 million ($1.4 million) Investors: Erasmus MC Biomedical...
BioCentury | Jun 22, 2009
Finance

Ebb & Flow

...general counsel at LSP. Schwarz and de Vries are also managing the €20 million Rotterdam-focused Erasmus MC Biomedical...
Items per page:
1 - 10 of 10